... Foundation. "At that time, Stribild's price was 35% more than Atripla, the company's best selling combination HIV/AIDS treatment, and made Stribild the highest priced first-line combination AIDS therapy. Now, Gilead has set a new benchmark for ...
http://ift.tt/1jLaBu6
http://ift.tt/1jLaBu6
No comments:
Post a Comment